Tourette's syndrome: From behaviour to biology

Research output: Contribution to journalReview articlepeer-review

233 Scopus citations


Tourette's syndrome (TS) is a chronic neuropsychiatric disorder characterised by motor and vocal tics. Diagnosis is based solely on clinical criteria. The prevalence of this syndrome is estimated to be between one and ten per 1000 children and adolescents and the outcome is generally favourable; most patients improve by their late teens or early adulthood. Affected individuals are at increased risk of various comorbid neurobehavioural problems, the negative effects of which commonly exceed those of tics. Despite evidence that TS is an inherited disorder, the exact genetic abnormality is unknown. Environmental factors might have an important role in the expression of tics, and a poststreptococcal autoimmune cause has been proposed but is unproven. Brain imaging, neurophysiological, and post-mortem studies support involvement of cortical-striatal-thalamocortical pathways, but the definitive pathophysiological mechanism or neurotransmitter abnormality is unknown. Recent evidence, however, suggests a prefrontal dopaminergic abnormality. Traditional neuroleptics are the standard treatment for TS, but there is increasing interest in non-neuroleptic drugs, behavioural therapies, and surgical approaches.

Original languageEnglish (US)
Pages (from-to)149-159
Number of pages11
JournalLancet Neurology
Issue number3
StatePublished - Mar 1 2005

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'Tourette's syndrome: From behaviour to biology'. Together they form a unique fingerprint.

Cite this